| abstract |
Proposed new compounds of the pyrrolidine series, which have the structural formula (II) and which are potent and selective PDE4 inhibitors, as well as methods for their preparation. The use of compounds in the treatment of inflammatory diseases and other diseases, including elevated levels of cytokines, as well as disorders of the central nervous system (CNS), has also been described. |